GGrantIndex
← Leaderboards

Eric D Marsh

Children'S Hosp Of Philadelphia

$5,802,897
Attributed
$11,246,217
Total exposure
5
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.8M · FY201025
$5M$3.8M$2.5M$1.3M$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$16,760,635 · 6

By mechanism

P50$5,514,418 · 1
U01$4,693,682 · 1
R61$2,464,143 · 1
R01$1,828,367 · 1
T32$1,381,975 · 1
K02$878,050 · 1

Top collaborators

Most similar at Children'S Hosp Of Philadelphia

Same institution · by research overlap

Others in their field

Top investigators on “Electroencephalography

Research focus

ElectroencephalographyGenesFoundationsDisabilityGeneticFamilyTrainingBehavioralNovel TherapeuticsBiological MarkersEpilepsyStructurePhenotypeFutureLeadBrainChildOutputMouse ModelLifeVariantSeizuresAffectNational Institute Of Neurological Disorders And Stroke

Grant awards (27)

The Intellectual and Developmental Disabilities Research Center (IDDRC) at CHOP/Penn$1,379,212
P50 · FY2025 · HD
Multi-Site Validation of Biomarkers and Core Clinical Outcome Measures for Clinical Trials Readiness in CDKL5 Deficiency Disorder$782,432
U01 · FY2025 · NS
Development of Translatable Neurophysiological Biomarkers to Accelerate Therapeutic Development in Rett Syndrome$701,399
R61 · FY2025 · NS · contact PI
Training Program in Neurodevelopmental Disabilities$542,954
T32 · FY2025 · NS
Multi-site validation of biomarkers and core clinical outcome measures for clinical trial readiness in CDKL5 Deficiency Disorder - Supplement$77,998
U01 · FY2025 · NS
The Intellectual and Developmental Disabilities Research Center (IDDRC) at CHOP/Penn$1,380,120
P50 · FY2024 · HD
Multi-Site Validation of Biomarkers and Core Clinical Outcome Measures for Clinical Trials Readiness in CDKL5 Deficiency Disorder$859,629
U01 · FY2024 · NS
Development of Translatable Neurophysiological Biomarkers to Accelerate Therapeutic Development in Rett Syndrome$821,000
R61 · FY2024 · NS · contact PI
Training Program in Neurodevelopmental Disabilities$303,323
T32 · FY2024 · NS
Multi-site validation of biomarkers and core clinical outcome measures for clinical trial readiness in CDKL5 Deficiency Disorder$78,000
U01 · FY2024 · NS
The Intellectual and Developmental Disabilities Research Center (IDDRC) at CHOP/Penn$1,380,976
P50 · FY2023 · HD
Development of Translatable Neurophysiological Biomarkers to Accelerate Therapeutic Development in Rett Syndrome$941,744
R61 · FY2023 · NS · contact PI
Multi-Site Validation of Biomarkers and Core Clinical Outcome Measures for Clinical Trials Readiness in CDKL5 Deficiency Disorder$902,257
U01 · FY2023 · NS
Training Program in Neurodevelopmental Disabilities$535,698
T32 · FY2023 · NS
The Intellectual and Developmental Disabilities Research Center (IDDRC) at CHOP/Penn$1,374,110
P50 · FY2022 · HD
Multi-Site Validation of Biomarkers and Core Clinical Outcome Measures for Clinical Trials Readiness in CDKL5 Deficiency Disorder$924,239
U01 · FY2022 · NS
Multi-Site Validation of Biomarkers and Core Clinical Outcome Measures for Clinical Trials Readiness in CDKL5 Deficiency Disorder$1,069,127
U01 · FY2021 · NS
Seizure generation and network excitability in Arx related Infantile Spasms$366,406
R01 · FY2017 · NS · contact PI
Seizure generation and network excitability in Arx related Infantile Spasms$366,406
R01 · FY2016 · NS · contact PI
Seizure generation and network excitability in Arx related Infantile Spasms$366,406
R01 · FY2015 · NS · contact PI
Seizure generation and network excitability in Arx related Infantile Spasms$362,743
R01 · FY2014 · NS · contact PI
ARX related Interneuron dysfunction and intractable pediatric epilepsy$174,749
K02 · FY2014 · NS · contact PI
Seizure generation and network excitability in Arx related Infantile Spasms$366,406
R01 · FY2013 · NS · contact PI
ARX related Interneuron dysfunction and intractable pediatric epilepsy$164,555
K02 · FY2013 · NS · contact PI
ARX related Interneuron dysfunction and intractable pediatric epilepsy$179,582
K02 · FY2012 · NS · contact PI
ARX related Interneuron dysfunction and intractable pediatric epilepsy$179,582
K02 · FY2011 · NS · contact PI
ARX related Interneuron dysfunction and intractable pediatric epilepsy$179,582
K02 · FY2010 · NS · contact PI